Apart from the characteristic EV-biomarkers, other major proteins detected in the NB-EVs included fibronectin, cancer stem cell marker - prominin-1, immunosuppressive factor - B7-H3, and the ECM regulator – basigin, thus suggesting the potential of EVs in regulating the TME during NB progression (74). This evidence concerns the gene CD276 and neuroblastoma.